Seven Bridges Genomics, now operating under the name Velsera, is a leading biomedical data company that specializes in bioinformatics and data analytics to enhance healthcare research. The company offers a comprehensive suite of end-to-end bioinformatic solutions, which include access to extensive datasets, analytic workflows, algorithms, and cloud-computing infrastructure. This integrated approach accelerates the transition from raw experimental data to actionable insights, facilitating the discovery of new treatments and diagnostics. The platform is designed to support collaborative research by connecting teams and data in a secure, cloud-based environment, allowing for streamlined clinical trial research and improved speed to market.

The Seven Bridges Platform is a robust cloud-based environment that enables scalable biomedical data analysis. It allows research teams to store, analyze, and interpret bioinformatic data collaboratively, with on-demand allocation of storage and compute resources. The platform supports a wide array of bioinformatics tools and workflows, ensuring that users have access to the latest versions for accurate data analysis. Additionally, it emphasizes security and compliance, meeting stringent regulatory requirements for handling sensitive genomic information. The platform's unique Graph Genome technology enhances the accuracy of genetic variant detection by utilizing a pan-genome graph reference, which improves as more sequences are added, thereby providing deeper insights into population genomics.

United Kingdom

Seven Bridges is the industry-leading unified bioinformatics solutions company accelerating precision medicine by enabling the understanding of biomedical data.  Our platform, analytic tools, and services expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaboration with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale.

Seven Bridges Genomics

Company Details